Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab

Abstract

Tachyphylaxis can occur during the treatment of exudative AMD with ranibizumab. The precise mechanism for the development of tachyphylaxis is unclear. Both local and systemic factors might be involved.